⌘K

Login Start Free

Home/Filings/4/0001348362-20-000004

4//SEC Filing

Spissinger Allan Horst 4

Accession 0001348362-20-000004

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 2:23 PM ET

Size

13.8 KB

Accession

0001348362-20-000004

Insider Transaction Report

Form 4

Period: 2020-03-23

Lexaria Bioscience Corp.LXRP

Spissinger Allan Horst

CFO

Transactions

Other
stock options
2020-03-23−200,000→ 300,000 total
Exercise: $0.83From: 2017-12-01Exp: 2022-12-01→ common shares (200,000 underlying)
Other
stock options
2020-03-23−150,000→ 500,000 total
Exercise: $0.37From: 2017-06-01Exp: 2022-06-01→ common shares (150,000 underlying)
Other
stock options
2020-03-23−300,000→ 0 total
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ common shares (300,000 underlying)

Holdings

stock options
Exercise: $0.83From: 2017-12-01Exp: 2022-12-01→ common shares (200,000 underlying)
350,000
stock options
Exercise: $0.37From: 2017-06-01Exp: 2022-06-01→ common shares (150,000 underlying)
150,000
common shares
119,116
stock options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ common shares (300,000 underlying)
650,000

Footnotes (1)

[F1]Cancellation of Options

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001708848

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 2:23 PM ET
Size: 13.8 KB

View on SEC.gov